Filing Details
- Accession Number:
- 0001179110-12-005397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-20 13:00:00
- Reporting Period:
- 2012-03-16
- Filing Date:
- 2012-03-20
- Accepted Time:
- 2012-03-20 17:20:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205465 | Carl Hull | Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-16 | 6,354 | $43.72 | 53,321 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-16 | 5,729 | $47.42 | 59,050 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-16 | 12,083 | $66.56 | 46,967 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-16 | 6,354 | $0.00 | 6,354 | $43.72 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-16 | 5,729 | $0.00 | 5,729 | $47.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,480 | 2016-05-18 | No | 4 | M | Direct | |
| 69,271 | 2014-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2011.
- This transaction was executed in multiple trades at prices ranging from $66.34 to $66.80. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the reported transactions were effected.
- 25% of the shares subject to the stock option vested and became exercisable on May 18, 2010 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.
- The shares subject to the stock option vested and became fully exercisable as of March 1, 2011.
Billionaire Hedge Funds
